NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody
Article in Molecular Therapy (June 2024)
The most recent citing publications are shown below. View all 55 publications that cite this research output on Dimensions.
Article in Molecular Therapy (June 2024)
Book chapter (May 2024)
Article in Leukemia (April 2024)